跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO
Approved
STANDARD
EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO
Gedeon Richter Plc.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 15, 2024
Approval ID
00b8a19a94e0e490
Company
Gedeon Richter Plc.
Type
Standard
Approval Details
Approval Id
00b8a19a94e0e490
Drug Cima Aemps Name
EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO
Register Number
02223002IP4
Holder Company Name
Gedeon Richter Plc.
Marketing Company Name
Difarmed S.L.U.
Holder Company Detail Path
/organization/gedeon-richter-plc-dorog
Authorization Date
2024-10-15
Dosage Form
PARCHE TRANSDÉRMICO
Dose
203 microgramos/24 h + 33,9 microgramos/24 h
Route Of Administration
VÍA TRANSDÉRMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Gedeon Richter Plc.
Company Detail Path
/organization/gedeon-richter-plc-dorog
Company Information
Pharmaceutical Company Name
Gedeon Richter PLC. , Dorog
Country Name
Hungary
City Name
dorog,country_hu
Address
Esztergomi út 27.
Active Ingredients
NORELGESTROMINA
6 mg
ETINILESTRADIOL
600 µg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 15, 2024
Approval ID
00b8a19a94e0e490
Type
Standard
Back to CIMA-AEMPS Approvals